The Effect of 360° Virtual Reality Movies on Fear and Anxiety

Summary

To assess the effect of web-based 360° Virtual Reality movies on fear and anxiety, The investigators would like to assess the patient-perceived level of fear and anxiety quantitatively, making use of several questionnaires.

Conditions

• Prostate Cancer
• Head and Neck Cancer
• Brain Tumor
• Fear
• Anxiety
• Breast Cancer
• Lung Cancer

Interventions

OTHER

Questionnaire: SPIRIT

T0: Before the first intake at Maastro, the Trialpoli (TP) contacts a patient via phone to inform whether or not he is interested in participating in this study. If the patient shows interest in participating in the study, he will be invited for a consultation with the Trialpoli. This consultation takes place on the day of intake at Maastro. After consent, the patient is randomized to fill out T0 before or after the intake. T1: After filling out T0, the patient receives the ENGAGE information card with the url en QR code to the VR-movie. After watching the VR movie and before start RT the patient is asked to fill in T1. This questionnaire is distributed with instructions by the TP. T2: Between the 5th and the 15th radiation treatment, patients will be asked to fill in the questionnaires for the third and last time. The Patient Information Form (PIF) and Informed Consent (IC) are added in a separate document.

OTHER

Questionnaire: HADS

Hospital Anxiety and Depression Scale, 14 questions likert scale

OTHER

Questionnaire: QSC-R23

Dutch version of the Questionnaire on stress symptoms, 23 questions likert scale

OTHER

General questions

* Education level * Marietal status * Medication use (in order to assess influence on fear) * Previous cancer diagnosis * Acquired information on treatment * Expected fear and anxiety mitigation strategies * Other cancer treatments (e.g. chemotherapy no, prior to RT, during RT, or after RT; surgery prior to or after RT) * PROM at baseline

OTHER

Clinical data collected

Clinical data in HIX: * Age * Gender * Cancer type * WHO status * TNM

Sponsors & Collaborators

• Maastricht Radiation Oncology

  lead OTHER

Principal Investigators

• Cheryl Roumen · Maastricht University

• Maria Jacobs · Maastro

Study Design

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2023-06-16

Primary Completion

2025-05-13

Completion

2025-05-13

Countries

• Netherlands

Study Locations